Endothelin and the human kidney: a potential target for new drugs.
Karet
F E
FE
Davenport
A P
AP
D000818:Animals; D016572:Cyclosporine / Q000009:adverse effects; D016232:Endothelins / Q000037:antagonists & inhibitors / Q000502:physiology*; D006801:Humans; D007668:Kidney / Q000502:physiology*; D007674:Kidney Diseases / Q000139:chemically induced / Q000503:physiopathology / Q000517:prevention & control; D010456:Peptides, Cyclic / Q000494:pharmacology; D017466:Receptors, Endothelin / Q000378:metabolism
D016232:Endothelins; D010456:Peptides, Cyclic; D017466:Receptors, Endothelin; D016572:Cyclosporine; C072247:cyclo(Trp-Asp-Pro-Val-Leu)